(Total Views: 390)
Posted On: 08/29/2021 5:57:07 PM
Post# of 30038
.jpg)
Conflict of interest: [Fumi Urano] received
research funding from Eli Lilly, Ono
Pharmaceuticals, and Amarantus
BioScience for the development of
MANF-based regenerative therapy
for Wolfram syndrome, optic
nerve atrophy, and diabetes
https://df6sxcketz7bb.cloudfront.net/manuscri...188.v2.pdf
research funding from Eli Lilly, Ono
Pharmaceuticals, and Amarantus
BioScience for the development of
MANF-based regenerative therapy
for Wolfram syndrome, optic
nerve atrophy, and diabetes
https://df6sxcketz7bb.cloudfront.net/manuscri...188.v2.pdf
(0)
(0)Scroll down for more posts ▼
